Date :
Place : United States, San Jose
Contact Person:Ashutos Swain
Description:
One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes did not adversely impact products, processes, equipment, facilities, etc. A single inadequate change may lead to significant negative events, including release of sub-standard product or product recall. A pattern of inadequate changes may require costly and time-consuming system remediation efforts.Deadline for abstracts/proposals : 27th August 2021
Organized By :Complianceonline
Keynote Speakers :
Check the event website for more details.